One of the UK’s leading medical research facilities is to launch the second phase of its research into the effects of vitamin B12 on pregnant women.
Researchers at the University of Warwick made the announcement after receiving an £800,000 grant for the project from the Medical Research Council (MRC).
Alongside experts from the University of Southampton and King Edward Memorial Hospital in Pune, India, project leaders hope to use tests on 4,500 women to establish whether vitamin B12 can cut the risk of gestational diabetes (GDM).
GDM is a rapidly spreading disease. In seven out of ten cases, mothers who have GDM go on to develop full blown diabetes. And babies born to women with GDM are at a higher risk of developing obesity and diabetes as an adult.
Commenting on the research, diabetes expert at Warwick Medical School and George Eliot Hospital Dr Ponnusamy Saravanan said: “This research will study pregnant women and follow the growth and development of their babies. The current research is funded until childbirth and we hope to closely follow up both mothers and baby beyond.”